Author

Cheng Peng

Chengdu University of Traditional Chinese Medicine

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Alzahrani Walid Abdulwahab· 1 shared Chaoxiang ReniD· 1 shared Feizhou Huang· 1 shared Gang Deng· 1 shared Hongbo XuiD· 1 shared Hongwu Luo· 1 shared Huanan RaoiD· 1 shared Jin PaniD· 1 shared

Activity by Year

2018-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Alzahrani Walid Abdulwahab

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Intranasal Fritillaria taipaiensis nanovesicles alleviate acute lung injury via the lung-brain axis

Huanan Rao, Jin Pan, Jinxin Guo, Xiaominting Song, Shukun Gong, Tao Zhou, Qinghua Wu, Yan Huang, Wei Nie, Cheng Peng, Li Zheyuan, Chaoxiang Ren, Jin Pei

This study shows that intranasal Fritillaria taipaiensis nanovesicles reduce acute lung injury and associated brain inflammation by targeting the VEGFR1 pathway via the lung-brain axis.

bioRxiv · Sep 14, 2026 · PreprintImmunology

HIV protease inhibitor Saquinavir inhibits toll-like receptor 4 activation by targeting receptor dimerization

Cheng Peng, Gang Deng, Yong Wang, Alzahrani Walid Abdulwahab, Hongwu Luo, Feizhou Huang, Hongbo Xu

This study shows that Saquinavir inhibits both MyD88- and TRIF-dependent TLR4 signaling pathways by blocking receptor dimerization, suggesting it targets the TLR4 receptor complex.

bioRxiv · May 23, 2018 · PreprintImmunology